A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Thomas P. Monath, Farshad Guirakhoo et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2022Cited by 76
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19Wang-Da Liu, Wang‐Huei Sheng, Albert Qin et al.|Infectious Diseases and Therapy|2024Cited by 0